Incremental Hemodialysis: The TwoPlus Trial
NCT: NCT05828823 · RECRUITING
Brief Summary
This study is to prospectively compare clinical effectiveness between clinically- matched incremental hemodialysis and conventional hemodialysis in patients with incident kidney dysfunction requiring dialysis and residual kidney function. The study will enroll 350 patients on chronic hemodialysis and 140 caregivers of enrolled patients. Patients will be randomized in 1:1 ratio to either incremental start hemodialysis or conventional hemodialysis. Caregivers will be followed along with patients for an average period of 2 years post randomization.
Frequently Asked Questions
What is Incremental Hemodialysis: The TwoPlus Trial?
Incremental Hemodialysis: The TwoPlus Trial is a clinical trial registered under NCT05828823. Current status: RECRUITING.
What is the status of NCT05828823?
The current status of NCT05828823 (Incremental Hemodialysis: The TwoPlus Trial) is: RECRUITING.
When did Incremental Hemodialysis: The TwoPlus Trial start?
Incremental Hemodialysis: The TwoPlus Trial started on 2024-02-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.